Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
39
CLDI Quote, Financials, Valuation and Earnings
Last price:
$0.61
Seasonality move
:
-36.42%
Day range:
$0.57 - $0.64
52-week range:
$0.20 - $3.89
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.79x
Volume:
3.1M
Avg. volume:
28.5M
1-year change:
-65.4%
Market cap:
$19.6M
Revenue:
--
EPS (TTM):
-$15.03
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $449K | $45K | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -89.98% | -- | -- | |
| Cost of Revenues | -- | $94K | $14K | -- | -- | |
| Gross Profit | -- | $355K | $31K | -- | -- | |
| Gross Profit Margin | -- | 79.07% | 68.89% | -- | -- | |
| R&D Expenses | $3.2M | $4.7M | $7.3M | $13M | $8.9M | |
| Selling, General & Admin | $3.6M | $6.2M | $15.9M | $16M | $12.9M | |
| Other Inc / (Exp) | -$997K | $174K | -$2.1M | $656K | $333K | |
| Operating Expenses | $6.8M | $10.8M | $23.2M | $26.1M | $21.6M | |
| Operating Income | -$6.8M | -$10.5M | -$23.1M | -$26.1M | -$21.6M | |
| Net Interest Expenses | -- | $614K | $158K | -- | -- | |
| EBT. Incl. Unusual Items | -$7.9M | -$10.9M | -$25.4M | -$29.2M | -$22.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4K | $11K | $11K | $16K | $14K | |
| Net Income to Company | -$7.9M | -$10.9M | -$25.4M | -$29.2M | -$22.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | $66K | |
| Net Income to Common Excl Extra Items | -$7.9M | -$10.9M | -$25.4M | -$29.2M | -$22.1M | |
| Basic EPS (Cont. Ops) | -$2.21 | -$3.04 | -$7.08 | -$17.33 | -$2.97 | |
| Diluted EPS (Cont. Ops) | -$2.21 | -$3.04 | -$7.08 | -$17.33 | -$2.97 | |
| Weighted Average Basic Share | $3.6M | $3.6M | $3.6M | $1.7M | $8M | |
| Weighted Average Diluted Share | $3.6M | $3.6M | $3.6M | $1.7M | $8M | |
| EBITDA | -$7.7M | -$10.2M | -$25M | -$26.9M | -$19.7M | |
| EBIT | -$7.8M | -$10.3M | -$25.3M | -$28.1M | -$21.3M | |
| Revenue (Reported) | -- | $449K | $45K | -- | -- | |
| Operating Income (Reported) | -$6.8M | -$10.5M | -$23.1M | -$26.1M | -$21.6M | |
| Operating Income (Adjusted) | -$7.8M | -$10.3M | -$25.3M | -$28.1M | -$21.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | $2.6M | $2.7M | $2.4M | |
| Selling, General & Admin | -- | -- | $2.8M | $4M | $2.6M | |
| Other Inc / (Exp) | -- | -- | -$1.5M | -$216K | $25K | |
| Operating Expenses | -- | -- | $4.7M | $6.8M | $5M | |
| Operating Income | -- | -- | -$4.7M | -$6.8M | -$5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$6.5M | -$7.2M | -$5.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $4K | $4K | $3K | |
| Net Income to Company | -- | -- | -$6.5M | -$7.2M | -$5.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | $76K | |
| Net Income to Common Excl Extra Items | -- | -- | -$6.5M | -$7.2M | -$5M | |
| Basic EPS (Cont. Ops) | -- | -- | -$1.80 | -$2.03 | -$0.18 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$1.80 | -$2.03 | -$0.18 | |
| Weighted Average Basic Share | -- | -- | $3.6M | $3.6M | $27.1M | |
| Weighted Average Diluted Share | -- | -- | $3.6M | $3.6M | $27.1M | |
| EBITDA | -- | -- | -$6.1M | -$6.6M | -$4.6M | |
| EBIT | -- | -- | -$6.2M | -$7M | -$5M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -$4.7M | -$6.8M | -$5M | |
| Operating Income (Adjusted) | -- | -- | -$6.2M | -$7M | -$5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | $8.2M | $13.1M | $8.6M | |
| Selling, General & Admin | -- | -- | $12.2M | $17.2M | $11.5M | |
| Other Inc / (Exp) | -- | -- | -$3.3M | $2M | $574K | |
| Operating Expenses | -- | -- | $19.7M | $28.1M | $19.9M | |
| Operating Income | -- | -- | -$19.4M | -$28.1M | -$19.9M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$23.1M | -$30M | -$20M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $5K | $16K | $13K | |
| Net Income to Company | -- | -- | -- | -$30M | -$20M | |
| Minority Interest in Earnings | -- | -- | -- | -- | $142K | |
| Net Income to Common Excl Extra Items | -- | -- | -$23.1M | -$30M | -$19.9M | |
| Basic EPS (Cont. Ops) | -- | -- | -$6.42 | -$9.24 | -$15.03 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$6.42 | -$9.24 | -$15.03 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -$22.3M | -$27.4M | -$17.7M | |
| EBIT | -- | -- | -$22.7M | -$28.9M | -$19.3M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -$19.4M | -$28.1M | -$19.9M | |
| Operating Income (Adjusted) | -- | -- | -$22.7M | -$28.9M | -$19.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | $2.6M | $2.7M | $2.4M | |
| Selling, General & Admin | -- | -- | $2.8M | $4M | $2.6M | |
| Other Inc / (Exp) | -- | -- | -$1.5M | -$216K | $25K | |
| Operating Expenses | -- | -- | $4.7M | $6.8M | $5M | |
| Operating Income | -- | -- | -$4.7M | -$6.8M | -$5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$6.5M | -$7.2M | -$5.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $4K | $4K | $3K | |
| Net Income to Company | -- | -- | -$6.5M | -$7.2M | -$5.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | $76K | |
| Net Income to Common Excl Extra Items | -- | -- | -$6.5M | -$7.2M | -$5M | |
| Basic EPS (Cont. Ops) | -- | -- | -$1.80 | -$2.03 | -$0.18 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$1.80 | -$2.03 | -$0.18 | |
| Weighted Average Basic Share | -- | -- | $3.6M | $3.6M | $27.1M | |
| Weighted Average Diluted Share | -- | -- | $3.6M | $3.6M | $27.1M | |
| EBITDA | -- | -- | -$6.1M | -$6.6M | -$4.6M | |
| EBIT | -- | -- | -$6.2M | -$7M | -$5M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -$4.7M | -$6.8M | -$5M | |
| Operating Income (Adjusted) | -- | -- | -$6.2M | -$7M | -$5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $420K | $2.1M | $372K | $1.9M | $9.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | $111K | $769K | $387K | |
| Other Current Assets | $93K | $603K | $303K | $225K | $249K | |
| Total Current Assets | $513K | $2.7M | $786K | $4.3M | $10.2M | |
| Property Plant And Equipment | $723K | $585K | $1.1M | $5.3M | $3.8M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $616K | $66K | $725K | $373K | $152K | |
| Total Assets | $1.9M | $3.4M | $2.6M | $10M | $14.2M | |
| Accounts Payable | $822K | $510K | $2.1M | $2.8M | $2.1M | |
| Accrued Expenses | $1.5M | $3.5M | $5.3M | $5.4M | $2.3M | |
| Current Portion Of Long-Term Debt | $4.9M | $4.5M | $5.4M | $807K | $3.2M | |
| Current Portion Of Capital Lease Obligations | $336K | $136K | $116K | $1.1M | $1.3M | |
| Other Current Liabilities | $1.1M | $16.7M | $29.8M | -- | -- | |
| Total Current Liabilities | $8.9M | $26M | $43M | $10.2M | $9.5M | |
| Long-Term Debt | $6.4M | -- | -- | $2.1M | $600K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $24.3M | $35M | $53M | $18.3M | $12.2M | |
| Common Stock | $2K | $2K | $2K | $1K | $2K | |
| Other Common Equity Adj | $6K | -$1K | -$14K | -$47K | -$28K | |
| Common Equity | -$22.5M | -$31.6M | -$50.4M | -$8.2M | $1.5M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | $434K | |
| Total Equity | -$22.5M | -$31.6M | -$50.4M | -$8.2M | $2M | |
| Total Liabilities and Equity | $1.9M | $3.4M | $2.6M | $10M | $14.2M | |
| Cash and Short Terms | $420K | $2.1M | $372K | $1.9M | $9.6M | |
| Total Debt | -- | $5M | $5.4M | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | $1.1M | $10.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | $549K | $596K | |
| Other Current Assets | -- | -- | -- | $244K | $282K | |
| Total Current Assets | -- | -- | -- | $1.9M | $11.5M | |
| Property Plant And Equipment | -- | -- | -- | $5M | $3.4M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | $506K | $144K | |
| Total Assets | -- | -- | -- | $7.4M | $15.1M | |
| Accounts Payable | -- | -- | -- | $3.8M | $1.2M | |
| Accrued Expenses | -- | -- | -- | $3.3M | $1M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $4.2M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $1.1M | $1.3M | |
| Other Current Liabilities | -- | -- | -- | $567K | -- | |
| Total Current Liabilities | -- | -- | -- | $15M | $5.4M | |
| Long-Term Debt | -- | -- | -- | $3.4M | $600K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | $22M | $7.8M | |
| Common Stock | -- | -- | -- | $4K | $3K | |
| Other Common Equity Adj | -- | -- | -- | $11K | -$26K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | $358K | |
| Total Equity | -- | -- | -- | -$14.6M | $7.3M | |
| Total Liabilities and Equity | -- | -- | -- | $7.4M | $15.1M | |
| Cash and Short Terms | -- | -- | -- | $1.1M | $10.6M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$7.9M | -$10.9M | -$25.4M | -$29.2M | -$22.2M | |
| Depreciation & Amoritzation | $117K | $153K | $253K | $1.3M | $1.5M | |
| Stock-Based Compensation | $968K | $1.3M | $6.1M | $4.8M | $3M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$4.8M | -$7.8M | -$13.2M | -$27M | -$19.7M | |
| Capital Expenditures | -- | $206K | $428K | -- | -- | |
| Cash Acquisitions | -- | -- | -- | $9K | -- | |
| Cash From Investing | -$388K | -$215K | -$494K | -$478K | -$16K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $2M | $1.9M | $1.5M | $3.3M | $3.8M | |
| Long-Term Debt Repaid | -$162K | -$129K | -$119K | -$2.4M | -$1.9M | |
| Repurchase of Common Stock | -$175K | -- | -- | -- | -- | |
| Other Financing Activities | -$4K | $7.9M | $10.6M | $604K | $437K | |
| Cash From Financing | $4.7M | $9.8M | $12.1M | $29M | $27.4M | |
| Beginning Cash (CF) | $934K | $420K | $2.2M | $590K | $2.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$517K | $1.8M | -$1.6M | $1.6M | $7.7M | |
| Ending Cash (CF) | $420K | $2.2M | $590K | $2.2M | $9.8M | |
| Levered Free Cash Flow | -$5.2M | -$8M | -$13.6M | -$27.6M | -$19.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$6.5M | -$7.2M | -$5.1M | |
| Depreciation & Amoritzation | -- | -- | $183K | $374K | $394K | |
| Stock-Based Compensation | -- | -- | $1.4M | $888K | $607K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$3.1M | -$3.8M | -$7.1M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$137K | -$5K | -$7K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $2.4M | $3.2M | -- | |
| Long-Term Debt Repaid | -- | -- | -$19K | -$23K | -$1.7M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | $1.3M | -$162K | -$301K | |
| Cash From Financing | -- | -- | $3.8M | $3M | $8.1M | |
| Beginning Cash (CF) | -- | -- | $590K | $2.2M | $9.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | $17K | -- | |
| Additions / Reductions | -- | -- | $547K | -$823K | $970K | |
| Ending Cash (CF) | -- | -- | $1.1M | $1.4M | $10.8M | |
| Levered Free Cash Flow | -- | -- | -$3.2M | -$3.8M | -$7.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$30M | -$20M | |
| Depreciation & Amoritzation | -- | -- | -- | $1.4M | $1.6M | |
| Stock-Based Compensation | -- | -- | $1.4M | $4.3M | $2.7M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -$27.7M | -$23M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | $9K | -- | |
| Cash From Investing | -- | -- | -- | -$346K | -$18K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $4.1M | $600K | |
| Long-Term Debt Repaid | -- | -- | -- | -$2.4M | -$3.5M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -$837K | $298K | |
| Cash From Financing | -- | -- | -- | $28.3M | $32.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $213K | $9.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -$28.2M | -$23M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$6.5M | -$7.2M | -$5.1M | |
| Depreciation & Amoritzation | -- | -- | $183K | $374K | $394K | |
| Stock-Based Compensation | -- | -- | $1.4M | $888K | $607K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$3.1M | -$3.8M | -$7.1M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$137K | -$5K | -$7K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $2.4M | $3.2M | -- | |
| Long-Term Debt Repaid | -- | -- | -$19K | -$23K | -$1.7M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | $1.3M | -$162K | -$301K | |
| Cash From Financing | -- | -- | $3.8M | $3M | $8.1M | |
| Beginning Cash (CF) | -- | -- | $590K | $2.2M | $9.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | $17K | -- | |
| Additions / Reductions | -- | -- | $547K | -$823K | $970K | |
| Ending Cash (CF) | -- | -- | $1.1M | $1.4M | $10.8M | |
| Levered Free Cash Flow | -- | -- | -$3.2M | -$3.8M | -$7.1M | |
Get CLDI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CLDI
Sector
P/E ratio
--
23.88x
PEG ratio
--
0.00x
P/B ratio
2.79x
1.80x
Price / LTM sales
--
1.65x
Growth Metrics
CLDI
Sector
Revenue growth
--
4.06%
Earnings growth
--
7.46%
Revenue (5-year growth)
--
8.01%
Earnings forecast
-$0.11
-$0.20
Profitability
CLDI
Sector
Profitability FY 2023
--
$47.5M
Return on invested capital
--
-16.26%
Return on assets
--
-13.27%
Return on equity
--
-18.61%
Earnings Date
Last Earnings Date
May
14
Next Earnings Date
Aug
13
Estimated Next Earnings Date
Aug
13
Balance Sheet
CLDI
Sector
Total cash
$10.6M
$35.5M
Short term investments
--
$29.7M
Total assets
$14.2M
$106.9M
Long term debt
--
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
72
SBET alert for Jul 18
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
